Chan, Alvin Man Lung
Ng, Angela Min Hwei
Yunus, Mohd Heikal Mohd
Idrus, Ruszymah Hj
Law, Jia Xian
Yazid, Muhammad Dain
Chin, Kok-Yong
Yusof, Mohd Rafizul Mohd
Ng, See Nguan
Koh, Benson
Lokanathan, Yogeswaran http://orcid.org/0000-0002-9548-6490
Funding for this research was provided by:
Universiti Kebangsaan Malaysia (FF-2020-469/1, DPK-2021-006)
Ming Medical Sdn. Bhd. (FF-2020-469)
Article History
Received: 2 March 2023
Accepted: 26 May 2024
First Online: 5 June 2024
Declarations
:
: The animal study protocol was approved by the UKMREC (JEP-2020–790) and UKMAEC (TEC/FP/2020/YOGESWARAN/23-SEPT./1124-OCT.-2020-SEPT-2023) with adherence to Declaration of Helsinki, for project title “Safety and efficacy study of allogeneic mesenchymal stem cell therapy for treatment for Metabolic Syndrome in Sprague Dawley rat” from September 2020 to September 2023. Likewise, use of human WJ-MSC cells was acquired through approved Human Primary Cell Banking (UKM 1.5.3.5/244/FF-2015–376). The umbilical cord tissues were obtained with consent from maternal volunteers who were undergoing scheduled Caesarean sections.
: All authors have declared no conflict of interest to report.